Original Article

Pain Scores and Exposure Rates after Polypropylene Mesh for Pelvic Organ Prolapse

Authors: Jana D. Illston, MD, Jeffrey B. Garris, MD, MS, Holly E. Richter, MD, PhD, Thomas L. Wheeler, MD, MSPH

Abstract

Objectives: To characterize pain and exposure after Prolift placement and identify risk factors.

Methods: A case series of women who underwent Prolift vaginal mesh were surveyed. Pain was assessed using a visual analog scale. Exposure was evaluated clinically.

Results: Of 183 eligible patients, 160 completed the survey, and 45 returned for examination. Mean preoperative pain score was 0.97 and postoperative was 1.35 ( P = 0.12). Pre- and postoperative pain scores by compartment were: anterior (1.34 vs 1.25, mean change −0.09, P = 0.84), posterior (1.30 vs 1.56, mean change 0.26, P = 0.72), and total (0.63 vs 1.34, mean change 0.71, P = 0.05). Graft exposure was confirmed in 23 of 183 patients (12.6%); however, because asymptomatic patients were not examined, the true exposure rate may be underestimated. Hematoma formation is independently associated with mesh exposure, adjusted odds ratio 18.4 (95% confidence interval 3.4–147.4, P = 0.01).

Conclusions: Although pain scores did not increase overall, there was a trend toward increased pain score in the patients with total (anterior and posterior) Prolift. Hematoma formation was significantly associated with mesh exposure.

 

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Wu JM, Vaughan CP, Goode PS, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol 2014;123:141-148.
 
2. Wu JM, Matthews CA, Conover MM, et al. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol 2014;123:1201-1026.
 
3. Withagen MI, Milani AL, den Boon J, et al. Trocar-guided mesh compared with conventional vaginal repair in recurrent prolapse: a randomized controlled trial. Obstet Gynecol 2011;117(2 Pt 1):242-250.
 
4. Maher C, Feiner B, Baessler K, et al. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2013;4:CD004014.
 
5. Hiltunen R, Nieminen K, Takala T, et al. Low-weight polypropylene mesh for anterior vaginal wall prolapse: a randomized controlled trial. Obstet Gynecol 2007;110(2 Pt 2):455-462.
 
6. Altman D, Vayrynen T, Engh ME, et al. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med 2011;364:1826-1836.
 
7. Nguyen JN, Burchette RJ. Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynecol 2008;111:891-898.
 
8. Weber AM, Walters MD, Piedmonte MR, et al. Anterior colporrhaphy: a randomized trial of three surgical techniques. Am J Obstet Gynecol 2001;185:1299-1306.
 
9. Sand PK, Koduri S, Lobel RW, et al. Prospective randomized trial of polyglactin 910 mesh to prevent recurrence of cystoceles and rectoceles. Am J Obstet Gynecol 2001;184:1357-1364.
 
10. Maher C, Baessker K, Barber M, et al. Surgery for pelvic organ prolapse. In: Abrams P, Brubaker L, Cardozo C, et al., eds. 5th International Consultation on Incontinence. Paris: Health Publications, 2013.
 
11. Milani AL, Hinoul R, Gauld JM, et al. Trocar-guided mesh repair of vaginal prolapse using partially absorbable mesh: 1 year outcomes. Am J Obstet Gynecol 2011;204:74.e1-e8.
 
12. Culligan PJ, Littman PM, Salamon CG, et al. Evaluation of a transvaginal mesh delivery system for the correction of pelvic organ prolapse: subjective and objective findings at least 1 year after surgery. Am J Obstet Gynecol 2010;203:506.e1-e6.
 
13. Takahashi S, Obinata D, Sakuma T, et al. Tension-free vaginal mesh procedure for pelvic organ prolapse: a single-center experience of 310 cases with 1-year follow up. Int J Urol 2010;17:353-358.
 
14. Vaiyapuri GR, Han HC, Lee LC, et al. Use of Gynecare Prolift system in surgery for pelvic organ prolapse: 1-year outcome. Int Urogynecol J 2011;22:869-877.
 
15. Margulies RU, Lewicky-Gaupp C, Fenner DE, et al. Complication requiring reoperation following vaginal mesh kit procedures for prolapse. Am J Obstet Gynecol 2008;199:678.e1-e4.
 
16. Abbott S, Unger CA, Evans JM, et al. Evaluation and management of complications from synthetic mesh after pelvic reconstructive surgery: a multicenter study. Am J Obstet Gynecol 2014;210:163.e1-e8.
 
17. Marcus-Braun N, Bourret A, von Theobald P. Persistent pelvic pain following transvaginal mesh surgery: a cause for mesh removal. Eur J Obstet Gynecol Reprod Biol 2012;162:224-228.
 
18. Vollebregt A, Fischer K, Gietelink D, et al. Effects of vaginal prolapse surgery on sexuality in women and men; results from a RCT on repair with and without mesh. J Sex Med 2012;9:1200-1211.
 
19. Committee on Gynecologic Practice. Vaginal placement of synthetic mesh for pelvic organ prolapse. Female Pelvic Med Reconstr Surg 2012;18:5-9.
 
20. Baessler K, Hewson AD, Tunn R. Severe mesh complications following intravaginal slingplasty. Obstet Gynecol 2005;106:713-716.
 
21. Crosby EC, Abernethy M, Berger MB, et al. Symptom resolution after operative management of complications from transvaginal mesh. Obstet Gynecol 2014;123:134-139.
 
22. Diwadkar GB, Barber MD, Feiner B, et al. Complication and reoperation rates after apical vaginal prolapse surgical repair: a systematic review. Obstet Gynecol 2009;113(2 Pt 1):367-373.
 
23. Chmielewski L, Walters MD, Weber AM, et al. Reanalysis of a randomized trial of 3 techniques of anterior colporrhaphy using clinically relevant definitions of success. Am J Obstet Gynecol 2011;205:69.e1-e8.
 
24. US Food and Drug Administration. Update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse: FDA Safety Communication. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm. Published July 13, 2011. Accessed April 13, 2014.
 
25. US Food and Drug Administration. FDA public health notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. http://www.fda.gov/medicaldevices/safety/alertsandnotices/publichealthnotifications/ucm061976.htm. Published October 20, 2008. Accessed April 13, 2014.
 
26. Murphy M, Holzberg A, van Raalte H, et al. Time to rethink: an evidencebased response from pelvic surgeons to the FDA Safety Communication: ‘‘UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse’’. Int Urogynecol J 2012;23:5-9.
 
27. Iglesia CB, Sokol AI, Sokol ER, et al. Vaginal mesh for prolapse: a randomized controlled trial. Obstet Gynecol 2010;116(2 Pt 1):293-303.
 
28. Sung VW, Rogers RG, Schaffer JI, et al. Graft use in transvaginal pelvic organ prolapse repair: a systematic review. Obstet Gynecol 2008;112:1131-1142.
 
29. Milani AL, Withagen MI, The HS, et al. Sexual function following trocarguided mesh or vaginal native tissue repair in recurrent prolapse: a randomized controlled trial. J Sex Med 2011;8:2944-2953.
 
30. Altman D, Elmer C, Kiilholma P, et al. Sexual dysfunction after trocarguided transvaginal mesh repair of pelvic organ prolapse. Obstet Gynecol 2009;113:127-133.
 
31. Bartuzi A, Futyma K, Kulik-Rechberger B, et al. Transvaginal Prolift() mesh surgery due to advanced pelvic organ prolapse does not impair female sexual function: a prospective study. Eur J Obstet Gynecol Reprod Biol 2012;165:295-298.
 
32. Alperin M, Ellison R, Meyn L, et al. Two-year outcomes after vaginal prolapse reconstruction with mesh pelvic floor repair system. Female Pelvic Med Reconstr Surg 2013;19:72-78.
 
33. Jha S, Gray T. A systematic review and meta-analysis of the impact of native tissue repair for pelvic organ prolapse on sexual function. Int Urogynecol J 2015;26:321-327.
 
34. Abed H, Rahn DD, Lowenstein L, et al. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J 2011;22:789-798.
 
35. Sirls LT, McLennan GP, Killinger KA, et al. Exploring predictors of mesh exposure after vaginal prolapse repair. Female Pelvic Med Reconstr Surg 2013;19:206-209.
 
36. El-Khawand D, Wehbe SA, O’Hare PG 3rd, et al. Risk factors for vaginal mesh exposure after mesh-augmented anterior repair: a retrospective cohort study. Female Pelvic Med Reconstr Surg 2014;20:305-309.